These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22745655)

  • 1. Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS.
    Knippenberg S; Thau N; Dengler R; Brinker T; Petri S
    PLoS One; 2012; 7(6):e36857. PubMed ID: 22745655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.
    Li Y; Chigurupati S; Holloway HW; Mughal M; Tweedie D; Bruestle DA; Mattson MP; Wang Y; Harvey BK; Ray B; Lahiri DK; Greig NH
    PLoS One; 2012; 7(2):e32008. PubMed ID: 22384126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of N-acetyl-glucagon-like peptide-1 in primary motor neuron cultures derived from non-transgenic and SOD1-G93A ALS mice.
    Sun H; Knippenberg S; Thau N; Ragancokova D; Körner S; Huang D; Dengler R; Döhler K; Petri S
    Cell Mol Neurobiol; 2013 Apr; 33(3):347-57. PubMed ID: 23271639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
    Uccelli A; Milanese M; Principato MC; Morando S; Bonifacino T; Vergani L; Giunti D; Voci A; Carminati E; Giribaldi F; Caponnetto C; Bonanno G
    Mol Med; 2012 Jul; 18(1):794-804. PubMed ID: 22481270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
    Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
    J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice.
    Wang J; Hu W; Feng Z; Feng M
    Neurol Res; 2021 Mar; 43(3):199-209. PubMed ID: 33076784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice.
    Lee J; Ryu H; Kowall NW
    Biochem Biophys Res Commun; 2009 Sep; 387(1):202-6. PubMed ID: 19580782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice.
    de Munter JPJM; Shafarevich I; Liundup A; Pavlov D; Wolters EC; Gorlova A; Veniaminova E; Umriukhin A; Kalueff A; Svistunov A; Kramer BW; Lesch KP; Strekalova T
    CNS Neurosci Ther; 2020 May; 26(5):504-517. PubMed ID: 31867846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
    Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
    Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.